CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
7550-06-3 | | alpha-phenyl-1-piperidineacetic aci ethyl ester | | | | |
7550-08-5 | | alpha-p-tolyl-1-piperidineacetic aci ethyl ester | | | | |
7550-10-9 | | alpha-p-tolyl-4-morpholineacetic aci ethyl ester | | | | |
7550-11-0 | | 4-diazepine-1-acetic acid, hexahydro-4-methyl-alpha-p-tolyl-1h- ethyl ester | | | | |
7550-17-6 | | alpha-(p-chlorophenyl)-4-methyl-1-piperazineacetic aci ethyl ester | | | | |
7550-21-2 | | hexahydro-beta-phenyl-1h-azepine-1-ethano | | | | |
7550-23-4 | | beta-p-tolyl-1-piperidineethano | | | | |
7550-24-5 | | 4-phenyl-beta-p-tolyl-1-piperazineethano | | | | |
7550-27-8 | | beta-(p-ethoxyphenyl)-4-methyl-1-piperazineethano | | | | |
7550-28-9 | | beta-(p-chlorophenyl)-1-piperidineethano | | | | |
7550-29-0 | | beta-(p-chlorophenyl)-4-methyl-1-piperazineethano | | | | |
7550-31-4 | | alpha-phenyl-1-piperidineacetic aci hydrazide | | | | |
7550-35-8 | 超干溴化锂 | LIthium bromide solution | BrLi | 86.844 | 550-3℃ | 1265℃ |
7550-39-2 | | 5-chloromethyl-2-iminooxazoline | | | | |
7550-45-0 | (T-4)-四氯化钛 | Titanium atomic spectroscopy standard concentrate 1.00g Ti | Cl4Ti | 189.68 | −25 °C(lit.) | 135-136 °C(lit.) |
755002-43-8 | 1-环丁基-2-苯基乙酮 | 1-Cyclobutyl-2-phenylethanone | C12H14O | 174.2390 | | |
755002-90-5 | VU 0134992 | | C20H31BrN2O2 | 411.38 | | |
755008-06-1 | N',N'-dimethyl-N-[(3-methylphenyl)methyl]ethane-1,2-diamine | | C12H20N2 | 192.3 | | |
75501-71-2 | | carbobenzyloxyglycyclglycyl-l-methioninamide | | | | |
755011-90-6 | | 3-{[(4-aminophenyl)sulfonyl]amino}benzamide | | | | |
755013-53-7 | N'-(3,5-二甲基苯甲酰基)-N'-(2,2-二甲基戊-3-基)-3-甲氧基-2-甲基苯甲酰肼 | N'-(3,5-Dimethylbenzoyl)-N'-(2,2-dimethylpentan-3-yl)-3-methoxy-2-methylbenzohydrazide | C25H34N2O3 | 410.55 | | |
755013-59-3 | Veledimex racemate | | C27H38N2O3 | 438.6 | | |
755017-61-9 | | 2'-Bromo-2,6-dimethoxybiphenyl | C14H13BrO2 | 293.16 | 143-146 ℃(lit.) | |
755025-16-2 | (S)-1-(2,4-二甲氧基苄基)-5-氧代吡咯烷-3-羧酸 | (S)-1-(2,4-dimethoxybenzyl)-5-oxopyrrolidine-3-carboxylic acid | C14H17NO5 | 279.29 | | |
755026-53-0 | | 11h-dibenzo[b,e][1,4]diazepin-11-one, 3-bromo-5,10-dihydro- | | | | |
755026-96-1 | 3-甲氧基-4-硝基苯硼酸频那醇酯 | 2-(3-Methoxy-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C13H18BNO5 | 279.0900 | | |
755027-18-0 | 2-溴-5-碘苯甲醚 | 2-bromo-5-iodoanisole | C7H6BrIO | 312.93 | | 293.7ºC |
755027-21-5 | 4-氯-1-碘-2-甲氧基苯 | 4-chloro-1-iodo-2-methoxybenzene | C7H6ClIO | 268.481 | | |
755027-42-0 | 2-氟-5-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)吡啶 | 2-Fluoro-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C12H17BFNO2 | 237.078 | | 333.6±42.0 °C(Predicted) |
755030-85-4 | | 4-(chloromethyl)-2-(3-methoxyphenyl)-5-methyl-1,3-oxazole | | | | |
755031-80-2 | 5-氯-2-碘-4-甲基苯胺 | 5-chloro-2-iodo-4-methylaniline | C7H7ClIN | 267.49 | | |
755031-82-4 | 2-乙酰氨基-4-氯-5-甲基苯甲酸甲酯 | methyl 2-acetamido-4-chloro-5-methylbenzoate | | | | |
755034-06-1 | 3-氯-11-氧代-10,11-二氢-5h-二苯并[b,e][1,4]二氮杂-7-羧酸甲酯 | methyl 3-chloro-11-oxo-10,11-dihydro-5h-dibenzo[b,e][1,4]diazepine-7-carboxylate | | | | |
755037-03-7 | 瑞格非尼 | regorafenib | C21H15ClF4N4O3 | 482.82 | | 513.4°C |
755038-02-9 | 4-[[(7R)-8-环戊基-7-乙基-5,6,7,8-四氢-5-甲基-6-氧代-2-喋啶基]氨基]-3-甲氧基-n-(1-甲基-4-哌啶基)苯甲酰胺 | bi 2536 | C28H39N7O3 | 521.66 | | |
755038-65-4 | n-(反式-4-(4-(环丙基甲基)-1-哌嗪基)环己基)-4-(((7R)-7-乙基-5,6,7,8-四氢-5-甲基-8-异丙基-6-氧代-2-蝶啶基)氨基)-3-甲氧基苯甲酰胺 | volasertib (bi 6727) | C34H50N8O3 | 618.83 | | |
755039-53-3 | (2R)-2-[(2-氯-5-硝基-4-嘧啶基)环戊胺基]-丁酸甲酯 | BUTANOIC ACID, 2-[(2-CHLORO-5-NITRO-4-PYRIMIDINYL)CYCLOPENTYLAMINO]-, METHYL ESTER, (2R)- | C14H19ClN4O4 | 342.7781 | | |
755039-54-4 | (7R)-2-氯-8-环戊烷基-7-乙基-7,8-二氢-6(5h)-蝶啶酮 | (R)-2-chloro-8-cyclopentyl-7-ethyl-7,8-dihydropteridin-6(5h)-one | C13H17ClN4O | 280.75 | | |
755039-55-5 | (7R)-2-氯-8-环戊基-7-乙基-7,8-二氢-5-甲基-6(5h)-蝶啶酮 | (R)-2-chloro-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5h)-one | C14H19ClN4O | 294.78 | | 537.5±45.0°C at 760 mmHg |
755039-56-6 | (R)-4-((8-环戊基-7-乙基-5-甲基-6-氧代-5,6,7,8-四氢蝶啶-2-基)氨基)-3-甲氧基苯甲酸 | dtag targeting ligand 1 | C22H27N5O4 | 425.48 | | 710.7±70.0 °C(Predicted) |
755039-78-2 | 1-(四氢-2h-吡喃-4-基)哌啶-4-胺二盐酸盐 | 1-(tetrahydro-2h-pyran-4-yl)piperidin-4-amine dihydrochloride | C10H22Cl2N2O | 257.20 | | |
755039-90-8 | (1S,4S)-4-(4-(环丙基甲基)哌嗪-1-基)环己胺 | (1S,4S)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexanamine | C14H27N3 | 237.38 | | |
755039-92-0 | (3R)-1-乙基吡咯烷-3-胺 | (3R)-1-ethylpyrrolidin-3-amine | | | | |
75504-01-7 | 2-(1-溴乙基)吡啶 | 2-(1-bromoethyl)pyridine | C7H8BrN | 186.0491 | | |
75504-34-6 | | tamoxifen n-oxide | | | | |
75505-74-7 | | 2,4-bis(1-aziridinyl)-6-chloro-s-triazin | | | | |
75507-25-4 | | 1,4,7,10,13-Pentaoxacyclopentadecane-2-methanol | C11H22O6 | 250.29 | | 135℃(1.5 |
75507-26-5 | 2-羟基甲基-12-冠醚-4 | 2-hydroxymethyl-12-crown-4 | C9H18O5 | 206.23 | | 125℃(0.0 |
75507-65-2 | 三氯化硼-2-氯乙醇试剂(5-10%)[用于酯化](1ml×10) | | | | | |
75507-68-5 | | ester, (z)-2-butenedioate (1:1) | C15H17FN4O2·C4H4O4 | 420.40 | 177°C(lit.) | |